# NAMSA – FDA Inspection, Sep 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/namsa/f0cc42ba-d14f-4f42-ad25-9ccbd45b9421
Source feed: FDA_Inspections

> FDA inspection 1026806 of NAMSA, September 15, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026806
- Company Name: NAMSA
- Inspection Date: 2017-09-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1084597 - 2019-03-27](https://www.keypedia.com/records/fda_inspections/namsa/ffb33801-1e35-4a94-9f2b-1fab7d50d838)
- FDA Inspection 904618 - 2014-06-11
- FDA Inspection 788447 - 2012-04-05
- FDA Inspection 683802 - 2010-03-31

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/carla-j-lundi/a10ed698-54fe-4635-a766-8c31f501dfb2)
- [Company Rep](https://www.keypedia.com/people/xiaoping-guan/191018c9-9f60-4db0-a9eb-48314b53e515)

Company: https://www.keypedia.com/companies/namsa/75e0a630-1969-447d-8b12-7ed05ebc324f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d